Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: Implications for fragile X syndrome carrier and newborn screening

This publication has 46 references indexed in Scilit:

• Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA
  American Journal of Human Genetics, 2009
• A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk Populations
  The Journal of Molecular Diagnostics, 2008
• Molecular testing for Fragile X Syndrome: Lessons learned from 119,232 tests performed in a clinical laboratory
  Genetics in Medicine, 2007
• Technical Validation of a Tm Biosciences Luminex-Based Multiplex Assay for Detecting the American College of Medical Genetics Recommended Cystic Fibrosis Mutation Panel
  The Journal of Molecular Diagnostics, 2006
• Cost-effectiveness analysis of prenatal population-based fragile X carrier screening
  American Journal of Obstetrics and Gynecology, 2005
• Direct Visualization of Cystic Fibrosis Transmembrane Regulator Mutations in the Clinical Laboratory Setting
  Clinical Chemistry, 2004
• A simple multiplex FRAXA, FRAXE, and FRAXF PCR assay convenient for wide screening programs
  Human Mutation, 1999
• Single-cell analysis of unstable genes
  Journal of Assisted Reproduction and Genetics, 1996
• Population screening for fragile X
  The Lancet, 1992
• Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
  Cell, 1991